James O. Wilson

Array ( [id] => 3977250 [patent_doc_number] => 05905071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Glycosylamides of 2-aminoacylamino-2-deoxy sugars' [patent_app_type] => 1 [patent_app_number] => 8/605031 [patent_app_country] => US [patent_app_date] => 1996-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6856 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/905/05905071.pdf [firstpage_image] =>[orig_patent_app_number] => 605031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890511 [patent_doc_number] => 05834446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Nerve process growth modulators' [patent_app_type] => 1 [patent_app_number] => 8/668189 [patent_app_country] => US [patent_app_date] => 1996-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6759 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 269 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834446.pdf [firstpage_image] =>[orig_patent_app_number] => 668189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761820 [patent_doc_number] => 05852000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Cardiac rehabilitation agent' [patent_app_type] => 1 [patent_app_number] => 8/665505 [patent_app_country] => US [patent_app_date] => 1996-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3904 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852000.pdf [firstpage_image] =>[orig_patent_app_number] => 665505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874340 [patent_doc_number] => 05763596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'C-4\' modified adenosine kinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/660505 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25217 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763596.pdf [firstpage_image] =>[orig_patent_app_number] => 660505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3863321 [patent_doc_number] => 05795977 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Water soluble adenosine kinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/660532 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28019 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795977.pdf [firstpage_image] =>[orig_patent_app_number] => 660532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874361 [patent_doc_number] => 05763597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Orally active adenosine kinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/660506 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19624 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763597.pdf [firstpage_image] =>[orig_patent_app_number] => 660506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808900 [patent_doc_number] => 05831075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Amino acid ester of nucleoside analogues' [patent_app_type] => 1 [patent_app_number] => 8/564080 [patent_app_country] => US [patent_app_date] => 1996-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1902 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831075.pdf [firstpage_image] =>[orig_patent_app_number] => 564080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625618 [patent_doc_number] => 05608043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Process for the preparation of 2-deoxy-2,2-difluoro-.beta.-D-ribo-pentopyranose compounds' [patent_app_type] => 1 [patent_app_number] => 8/649934 [patent_app_country] => US [patent_app_date] => 1996-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4584 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/608/05608043.pdf [firstpage_image] =>[orig_patent_app_number] => 649934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3882472 [patent_doc_number] => 05798340 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Nucleotide analogs' [patent_app_type] => 1 [patent_app_number] => 8/617849 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 71031 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798340.pdf [firstpage_image] =>[orig_patent_app_number] => 617849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833038 [patent_doc_number] => 05712259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome' [patent_app_type] => 1 [patent_app_number] => 8/636202 [patent_app_country] => US [patent_app_date] => 1996-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4204 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712259.pdf [firstpage_image] =>[orig_patent_app_number] => 636202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764723 [patent_doc_number] => 05852188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Oligonucleotides having chiral phosphorus linkages' [patent_app_type] => 1 [patent_app_number] => 8/635009 [patent_app_country] => US [patent_app_date] => 1996-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12247 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852188.pdf [firstpage_image] =>[orig_patent_app_number] => 635009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109417 [patent_doc_number] => 06022963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Synthesis of oligonucleotide arrays using photocleavable protecting groups' [patent_app_type] => 1 [patent_app_number] => 8/630148 [patent_app_country] => US [patent_app_date] => 1996-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7554 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022963.pdf [firstpage_image] =>[orig_patent_app_number] => 630148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986346 [patent_doc_number] => 05959100 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Pyrimidine nucleosides as therapeutic and diagnostic agents' [patent_app_type] => 1 [patent_app_number] => 8/622772 [patent_app_country] => US [patent_app_date] => 1996-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11416 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 379 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/959/05959100.pdf [firstpage_image] =>[orig_patent_app_number] => 622772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621266 [patent_doc_number] => 05641753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => '10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined with sulfisoxazole' [patent_app_type] => 1 [patent_app_number] => 8/622250 [patent_app_country] => US [patent_app_date] => 1996-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1023 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641753.pdf [firstpage_image] =>[orig_patent_app_number] => 622250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733226 [patent_doc_number] => 05693771 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Methods for making nucleoside analogs' [patent_app_type] => 1 [patent_app_number] => 8/615669 [patent_app_country] => US [patent_app_date] => 1996-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40859 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693771.pdf [firstpage_image] =>[orig_patent_app_number] => 615669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013722 [patent_doc_number] => 05962674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Synthesis of oligonucleotides containing alkylphosphonate internucleoside linkages' [patent_app_type] => 1 [patent_app_number] => 8/606915 [patent_app_country] => US [patent_app_date] => 1996-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4679 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962674.pdf [firstpage_image] =>[orig_patent_app_number] => 606915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787551 [patent_doc_number] => 05840714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, pharmaceutical preparations containing said inclusion complexes and methods for using same' [patent_app_type] => 1 [patent_app_number] => 8/602729 [patent_app_country] => US [patent_app_date] => 1996-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 64 [patent_no_of_words] => 11048 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840714.pdf [firstpage_image] =>[orig_patent_app_number] => 602729 [rel_patent_id] =>[rel_patent_doc_number] =>)